TC.NASDAQBIOILSTC.NASDAQBIOILSTC.NASDAQBIOILS

TC.NASDAQBIOILS

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪7.61 M‬ILS
Fund flows (1Y)
‪−959.95 M‬ILS
Dividend yield (indicated)
Discount/Premium to NAV
1.6%
Shares outstanding
‪228.89 K‬
Expense ratio
0.30%

About TC.NASDAQBIOILS


Brand
Tachlit
Home page
Inception date
Nov 27, 2018
Index tracked
NASDAQ Biotechnology Index
Replication method
Physical
Management style
Passive
Dividend treatment
Capitalizes
Primary advisor
Meitav Mutual Funds Ltd.
ISIN
IL0011448649
The fund's goal try to achieve results as similar as possible to the rate of change in the index of change in the exchange rate of the US dollar.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Biotechnology
Strategy
Exchange-specific
Geography
U.S.
Weighting scheme
Market cap
Selection criteria
NASDAQ - listed
What's in the fund
Exposure type
Bonds, Cash & Other
Government
Cash
Stock breakdown by region
5%94%
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Broaden your horizons with more funds linked to TCH.F142 via country, focus, and more.